image
Halozyme Therapeutics, Inc. HALO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 45.65
-15.4 %
$ 5.81 B
Market Cap
16.42
P/E
CASH FLOW STATEMENT
389 M OPERATING CASH FLOW
61.83%
Growth Rates
1Year 61.83%
3Years 91.36%
5Years 58.01%
7Years 38.37%
10Years 25.73%
-96.9 M INVESTING CASH FLOW
80.10%
Growth Rates
1Year 80.10%
3Years -30.78%
5Years -108.99%
7Years -3.38%
10Years -7.31%
-408 M FINANCING CASH FLOW
-112.59%
Growth Rates
1Year -112.59%
3Years -56.58%
5Years -44.93%
7Years -20.59%
10Years -32.97%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Halozyme Therapeutics, Inc.
image
Net Income 282 M
Depreciation & Amortization 84.9 M
Capital Expenditures -15.3 M
Stock-Based Compensation 36.6 M
Change in Working Capital -38.7 M
Others -6.24 M
Free Cash Flow 373 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001
OPERATING CASH FLOW
Net Income 281.6 202.1 402.7 129.1 (72.2) (80.3) 63.0 (103.0) (32.2) (68.4) (83.5) (53.6) (19.8) (53.2) (58.4) (48.7) (23.9) (14.8) (13.3) (9.1) 79.1 K 65.3 K 39.7 K
Depreciation & Amortization 84.9 49.6 3.0 3.3 4.1 2.4 2.2 2.4 1.7 1.8 1.2 1.1 1.1 1.5 1.4 1.0 0.6 0.2 0.2 0.1 0 0 0
Deferred Income Tax 34.5 40.0 (155.4) 0.6 0.5 (3.1) (0.3) 0.6 0.9 1.7 1.1 7.37 K 0 0 0 (3.7) 0 0 0 0 0 0 0
Stock Based Compensation 36.6 24.4 20.8 17.2 34.8 35.7 30.7 25.6 20.8 15.3 9.5 8.3 5.6 4.9 4.5 3.7 0 0 0 0 0 0 0
Other Operating Activities (10.3) 9.9 24.6 13.6 (2.0) 1.7 17.8 7.1 1.2 2.0 0.2 8.62 K 1.57 K 13.5 K 2.68 K 3.7 2.6 1.3 0.2 98.2 K 2.34 K 2.34 K 1.99 K
Change in Working Capital (38.7) (86.0) 3.7 (108.4) (50.5) (5.9) 20.7 17.0 (29.5) 0.1 22.1 (20.2) (21.2) 1.5 12.2 8.5 20.6 20.3 (0.1) 1.2 27 K 7.14 K 3.29 K
Cash From Operations 388.6 240.1 299.4 55.5 (85.4) (49.5) 134.1 (50.4) (37.1) (47.5) (49.3) (64.3) (34.4) (45.4) (40.1) (35.4) (0.1) 7.1 (13.0) (7.7) 49.7 K 55.8 K 34.4 K
INVESTING CASH FLOW
Capital Expenditures (15.3) (4.8) (1.5) (2.5) (4.0) (4.7) (1.4) (3.1) (2.4) (1.4) (2.3) (1.4) (0.8) (0.6) (1.5) (1.2) (2.4) (0.4) (0.4) (0.2) 0 0 0
Other Items (81.6) (482.2) (404.8) 80.9 (1.5) 7.2 (162.4) (73.6) 8.2 (31.6) (45.6) 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities (96.9) (487.0) (406.3) 78.4 (5.5) 2.5 (163.7) (76.8) 5.9 (33.0) (47.9) (1.4) (0.8) (0.6) (1.5) (1.2) (2.4) (0.4) (0.4) (0.2) 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased (402.4) (200.0) (350.1) (150.1) (200.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid (13.5) 624.5 415.8 (19.6) 339.3 (77.5) (16.0) 148.8 0 0 20.0 29.7 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 7.9 (62.2) 12.1 63.4 13.9 13.7 12.8 1.9 13.1 6.8 25 039.2 1.7 4.7 1.9 7.2 0 0 0 0 7.9 0 0 0
Cash From Financing Activities (408.0) 362.4 77.9 (106.3) 153.2 (63.8) 131.7 150.6 13.1 114.5 25.1 112.8 4.7 61.8 45.4 2.6 56.0 18.3 16.5 23.4 0 0.1 60.5 K
CHANGE IN CASH
Net Change In Cash (116.3) 115.5 (29.0) 27.5 62.2 (110.8) 102.0 23.5 (18.1) 34.0 (72.1) 47.1 (30.4) 15.8 3.7 (34.0) 53.5 25.1 3.1 15.5 49.7 K 71.1 K 26.1 K
FREE CASH FLOW
Free Cash Flow 373.3 235.3 298.0 53.0 (89.5) (54.2) 132.7 (53.5) (39.4) (48.9) (51.6) (65.7) (35.2) (46.0) (41.6) (36.5) (2.5) 6.7 (13.3) (7.9) 49.7 K 55.8 K 34.4 K